• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Inspections, Compliance, Enforcement, and Criminal Investigations

  • Print
  • Share
  • E-mail

Best Price Rx - Close Out Letter 6/28/12


Department of Health and Human Services' logoDepartment of Health and Human Services

Public Health Service
Food and Drug Administration

Silver Spring, MD 20993-0002

June 28, 2012

Best Price Rx
#501-2906 West Broadway
Vancouver, BC, Canada V6K 208

To Whom It May Concern:

The Food and Drug Administration (FDA) has completed an evaluation of your pharmacy’s corrective actions in response to our Warning Letter dated May 24, 2012. Based on our evaluation, it appears that you have addressed the violations contained in this Warning Letter. Future FDA regulatory activities will further assess the adequacy and sustainability of these corrections.

This letter does not relieve you or your pharmacy from the responsibility of taking all necessary steps to assure sustained compliance with the Federal Food, Drug, and Cosmetic Act and its implementing regulations or with other relevant legal authority. The Agency expects you and your pharmacy to maintain compliance and will continue to monitor your state of compliance. This letter will not preclude any future regulatory action should violations be observed.



Thomas Christl, Office Director (Acting)
Office of Drug Security, Integrity and Recalls
Office of Compliance
Center for Drug Evaluation and Research